Pages that link to "Q40052252"

The following pages link to Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma (Q40052252):

Displaying 13 items.

• Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma (Q36689140) (← links)
• ErbB receptors in the biology and pathology of the aerodigestive tract (Q37263452) (← links)
• miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4. (Q37504370) (← links)
• Potential of ErbB4 antibodies for cancer therapy. (Q37658764) (← links)
• Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers (Q38073827) (← links)
• Developmental pathways hijacked by osteosarcoma (Q38219835) (← links)
• MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets (Q39166706) (← links)
• miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer (Q41472283) (← links)
• Prognostic and risk factors in patients with locally advanced cutaneous squamous cell carcinoma of the trunk and extremities (Q42798358) (← links)
• Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). (Q45210729) (← links)
• Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients (Q47948456) (← links)
• ErbB4 as a potential molecular target in the treatment of esophageal squamous cell cancers. (Q54300172) (← links)
• Fentanyl inhibits proliferation and invasion via enhancing miR-302b expression in esophageal squamous cell carcinoma. (Q55416925) (← links)